Loading...
Market
How many Shanghai-based biopharmaceutical companies will receive CNY100 million in funding by the end of 2024?
3
Resolution / Starting Odds
0 companies • 25%
1 company • 25%
2-3 companies • 25%
4 or more companies • 25%
Official announcements from Shanghai municipal government or the companies' press releases
Story
Shanghai Unveils Plan to Boost Biopharmaceutical Industry with CNY100 Million Each in Funding
Jul 31, 2024, 10:27 AM
Shanghai has announced a comprehensive plan to support its biopharmaceutical industry, pledging millions of dollars over five years to reward local drugmakers that break into global markets. The municipal government will provide up to CNY100 million (USD13.8 million) each to companies based in the city for novel drug research, development, and clinical trials. This initiative is part of a broader set of 37 measures aimed at bolstering Shanghai's health care sector.
View original story
Similar markets
None • 25%
1-3 targets • 25%
4-6 targets • 25%
More than 6 targets • 25%
Less than 10 • 25%
10-20 • 25%
21-30 • 25%
More than 30 • 25%
No additional funding • 25%
Up to $10 million • 25%
$10 million to $50 million • 25%
Over $50 million • 25%
10-12 • 25%
13-15 • 25%
16-18 • 25%
19 or more • 25%
0-10 • 25%
11-20 • 25%
21-30 • 25%
31+ • 25%
0-1 companies • 25%
2-3 companies • 25%
4-5 companies • 25%
More than 5 companies • 25%
1-3 drugs/vaccines • 25%
4-6 drugs/vaccines • 25%
7-9 drugs/vaccines • 25%
10 drugs/vaccines • 25%
None • 25%
1-2 institutions • 25%
3-5 institutions • 25%
More than 5 institutions • 25%
0-5 • 25%
6-10 • 25%
11-15 • 25%
16+ • 25%
Yes • 50%
No • 50%
Xaira Therapeutics • 25%
Mirador Therapeutics • 25%
Formation Bio • 25%
Other • 25%